1. Home
  2. BLLN vs CNX Comparison

BLLN vs CNX Comparison

Compare BLLN & CNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$128.58

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo CNX Resources Corporation

CNX

CNX Resources Corporation

HOLD

Current Price

$33.11

Market Cap

4.8B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
CNX
Founded
2016
1860
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
4.8B
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
BLLN
CNX
Price
$128.58
$33.11
Analyst Decision
Buy
Sell
Analyst Count
7
7
Target Price
$126.71
$35.71
AVG Volume (30 Days)
706.5K
2.0M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
763.33
EPS
N/A
2.18
Revenue
N/A
$2,239,134,000.00
Revenue This Year
$46.29
N/A
Revenue Next Year
$30.14
$11.14
P/E Ratio
N/A
$14.98
Revenue Growth
N/A
76.76
52 Week Low
$61.96
$27.72
52 Week High
$138.70
$43.62

Technical Indicators

Market Signals
Indicator
BLLN
CNX
Relative Strength Index (RSI) 63.97 47.31
Support Level $79.07 $32.83
Resistance Level $138.70 $34.33
Average True Range (ATR) 6.93 0.74
MACD -0.21 0.08
Stochastic Oscillator 91.96 55.18

Price Performance

Historical Comparison
BLLN
CNX

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About CNX CNX Resources Corporation

CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.

Share on Social Networks: